Horizon Therapeutics-Amgen deal could close Q3 if FTC block fails
Robert Galbraith | ReutersHorizon Therapeutics expects its $27.8 billion sale to Amgen to shut as early as the tip of ...
Robert Galbraith | ReutersHorizon Therapeutics expects its $27.8 billion sale to Amgen to shut as early as the tip of ...